awacke1/LOINC-Clinical-Terminology · Datasets at Hugging Face

LOINC_NUM stringlengths 3 8	COMPONENT stringlengths 2 246	PROPERTY stringlengths 1 29	TIME_ASPCT stringlengths 1 15	SYSTEM stringlengths 1 106	SCALE_TYP stringclasses 10 values	METHOD_TYP stringlengths 1 57 ⌀	CLASS stringlengths 2 24	CLASSTYPE int64 1 4	LONG_COMMON_NAME stringlengths 3 254	SHORTNAME stringlengths 2 51 ⌀	EXTERNAL_COPYRIGHT_NOTICE stringlengths 39 2.6k ⌀	STATUS stringclasses 4 values	VersionFirstReleased stringlengths 1 7	VersionLastChanged stringlengths 1 5
95814-0	Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69
95815-7	Altered level of consciousness	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Altered level of consciousness during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69
95816-5	Signs and Symptoms of Delirium (from CAM)	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	Signs and symptoms of delirium (from CAM) during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.72
95817-3	Oxygen/Gas.total	VFr	24H^max	Inhl gas	Qn	null	CLIN	2	Oxygen/Gas total 24 hour maximum Inhaled gas	FIO2 24h Max	null	ACTIVE	2.69	2.69
95818-1	Intravascular mean^during anesthesia	Pres	Pt	Pulmonary artery	Qn	null	BP.MOLEC	2	Pulmonary artery Mean blood pressure--during anesthesia	PA BP mean--during anesthesia	null	ACTIVE	2.69	2.69
95819-9	Intravascular diastolic^during anesthesia	Pres	Pt	Pulmonary artery	Qn	null	BP.MOLEC	2	Pulmonary artery Diastolic blood pressure--during anesthesia	PA BP dias--during anesthesia	null	ACTIVE	2.69	2.69
95820-7	Intravascular systolic^during anesthesia	Pres	Pt	Pulmonary artery	Qn	null	BP.MOLEC	2	Pulmonary artery Systolic blood pressure--during anesthesia	PA BP sys--during anesthesia	null	ACTIVE	2.69	2.69
95821-5	Intravascular mean^during anesthesia	Pres	Pt	Arterial system	Qn	Noninvasive	BP.MOLEC	2	Mean blood pressure by Noninvasive--during anesthesia	BP mean by Noninv--during anesthesia	null	ACTIVE	2.69	2.69
95822-3	Intravascular mean^during anesthesia	Pres	Pt	Arterial system	Qn	null	BP.MOLEC	2	Mean blood pressure--during anesthesia	BP mean--during anesthesia	null	ACTIVE	2.69	2.69
95823-1	SARS-related coronavirus E gene	PrThr	Pt	Saliva	Ord	Probe.amp.tar	MICRO	1	SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection	SARS-rel CoV E gene Sal Ql NAA+probe	null	ACTIVE	2.69	2.69
95824-9	SARS coronavirus 2 ORF1ab region	PrThr	Pt	Saliva	Ord	Probe.amp.tar	MICRO	1	SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection	SARS-CoV-2 ORF1ab Sal Ql NAA+probe	null	ACTIVE	2.69	2.69
95825-6	SARS coronavirus 2 Ab	PrThr	Pt	Bld.dot	Ord	IA	MICRO	1	SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay	SARS-CoV-2 Ab DBS Ql IA	null	ACTIVE	2.69	2.69
95826-4	SARS coronavirus 2 RNA panel	-	Pt	Saliva	-	Probe.amp.tar	PANEL.MICRO	1	SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection	SARS-CoV-2 RNA Pnl Sal NAA+probe	null	ACTIVE	2.69	2.7
95827-2	Viable CD3 cells/100 cells.CD3	NFr	Pt	^BPU	Qn	null	BLDBK	1	Viable CD3 cells/100 CD3 cells in Blood product unit	Viable CD3 cells/100 CD3 NFr BPU	null	ACTIVE	2.69	2.69
9582-8	Afipia felis Ab.IgG	Titr	Pt	Ser	Qn	IF	MICRO	1	Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence	A felis IgG Titr Ser IF	null	ACTIVE	1.0i	2.7
95828-0	T cell product characterization panel	-	Pt	^BPU	-	Flow cytometry	PANEL.BLDBK	1	T cell product characterization panel - Blood product unit by Flow cytometry (FC)	T cell product panel BPU FC	null	ACTIVE	2.69	2.69
95829-8	Viable CD45 cells/100 cells.CD45	NFr	Pt	^BPU	Qn	null	BLDBK	1	Viable CD45 cells/100 CD45 cells in Blood product unit	Viable CD45 cells/100 CD45 NFr BPU	null	ACTIVE	2.69	2.69
95830-6	Hematopoietic progenitor cell product characterization panel	-	Pt	^BPU	-	Flow cytometry	PANEL.BLDBK	1	Hematopoietic progenitor cell product characterization panel - Blood product unit by Flow cytometry (FC)	HPC product panel BPU FC	null	ACTIVE	2.69	2.69
95831-4	Lymphocyte dose in hematopoietic progenitor cell transfusion	NCnt	Pt	^Patient	Qn	null	BLDBK	1	Lymphocyte dose in hematopoietic progenitor cell transfusion [#/mass]	Lymphocyte dose in HPC trsplt Patient	null	ACTIVE	2.69	2.69
95832-2	CD3 dose in hematopoietic progenitor cell transfusion	NCnt	Pt	^Patient	Qn	null	BLDBK	1	CD3 dose in hematopoietic progenitor cell transfusion [#/mass]	CD3 dose in HPC transplant Patient	null	ACTIVE	2.69	2.69
95833-0	Nucleated cells	Num	Pt	^BPU	Qn	null	BLDBK	1	Nucleated cells [#] in Blood product unit	Nuc cell BPU	null	ACTIVE	2.69	2.69
95834-8	Mononuclear cells	Num	Pt	^BPU	Qn	null	BLDBK	1	Mononuclear cells [#] in Blood product unit	Mononuc Cells BPU	null	ACTIVE	2.69	2.69
95835-5	Cells.CD34	Num	Pt	^BPU	Qn	null	BLDBK	1	CD34 cells [#] in Blood product unit	CD34 Cells BPU	null	ACTIVE	2.69	2.69
9583-6	Afipia felis Ab.IgM	Titr	Pt	Ser	Qn	IF	MICRO	1	Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence	A felis IgM Titr Ser IF	null	ACTIVE	1.0i	2.7
95836-3	Cells.CD3	Num	Pt	^BPU	Qn	null	BLDBK	1	CD3 cells [#] in Blood product unit	CD3 Cells BPU	null	ACTIVE	2.69	2.69
95837-1	Mononuclear cell dose in hematopoietic progenitor cell transfusion	NCnt	Pt	^Patient	Qn	null	BLDBK	1	Mononuclear cell dose in hematopoietic progenitor cell transfusion [#/mass]	Mono Cell dose in HPC transplant Patient	null	ACTIVE	2.69	2.69
95838-9	Nucleated cells.recovered/Nucleated cells.total	NFr	Pt	^Patient	Qn	null	BLDBK	1	Nucleated cells.recovered/Nucleated cells.total	TNC Recovered/TNC NFr Patient	null	ACTIVE	2.69	2.69
95839-7	Mononuclear cells.recovered/Mononuclear cells.total	NFr	Pt	^Patient	Qn	null	BLDBK	1	Mononuclear cells.recovered/Mononuclear cells.total	Monos Recovered/Monos Total NFr Patient	null	ACTIVE	2.69	2.69
95840-5	Microscopic exam	Imp	Pt	Sputum	Nar	Microscopy	HEM/BC	1	Microscopic exam [Interpretation] in Sputum by Microscopy Narrative	Microscopic Spt Micro-Imp	null	ACTIVE	2.69	2.69
95841-3	Monocytes+Macrophages/100 leukocytes	NFr	Pt	Sputum	Qn	Manual count	HEM/BC	1	Monocytes+Macrophages/100 leukocytes in Sputum by Manual count	Monos+Macros/leuk NFr Spt Manual	null	ACTIVE	2.69	2.69
95842-1	Lymphocytes/100 leukocytes	NFr	Pt	Sputum	Qn	Manual count	HEM/BC	1	Lymphocytes/100 leukocytes in Sputum by Manual count	Lymphocytes/leuk NFr Spt Manual	null	ACTIVE	2.69	2.69
95843-9	Neutrophils/100 leukocytes	NFr	Pt	Sputum	Qn	Manual count	HEM/BC	1	Neutrophils/100 leukocytes in Sputum by Manual count	Neutrophils/leuk NFr Spt Manual	null	ACTIVE	2.69	2.69
9584-4	Babesia sp Ab.IgG	Titr	Pt	Ser	Qn	IF	MICRO	1	Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence	Babesia IgG Titr Ser IF	null	ACTIVE	1.0i	2.73
95844-7	Epithelial cells.squamous	NCnc	Pt	Sputum	Qn	Manual count	HEM/BC	1	Epithelial cells.squamous [#/volume] in Sputum by Manual count	Squamous # Spt Manual	null	ACTIVE	2.69	2.69
95845-4	Nucleated cells	NCnc	Pt	Sputum	Qn	Manual count	HEM/BC	1	Nucleated cells [#/volume] in Sputum by Manual count	Nuc cell # Spt Manual	null	ACTIVE	2.69	2.69
95846-2	Cell count & Differential panel	-	Pt	Sputum	Qn	Manual count	PANEL.HEM/BC	1	Cell count and Differential panel - Sputum by Manual count	Cell Cnt + Diff Pnl Spt Manual	null	ACTIVE	2.69	2.69
95847-0	Somatotropin^90M post dose macimorelin	MCnc	Pt	Ser	Qn	IA	CHEM	1	Somatotropin [Mass/volume] in Serum by Immunoassay --90 minutes post dose macimorelin	GH 90M p Macimorelin Ser IA-mCnc	null	ACTIVE	2.69	2.69
95848-8	Somatotropin^60M post dose macimorelin	MCnc	Pt	Ser	Qn	IA	CHEM	1	Somatotropin [Mass/volume] in Serum by Immunoassay --60 minutes post dose macimorelin	GH 60M p Macimorelin Ser IA-mCnc	null	ACTIVE	2.69	2.69
95849-6	Somatotropin^45M post dose macimorelin	MCnc	Pt	Ser	Qn	IA	CHEM	1	Somatotropin [Mass/volume] in Serum by Immunoassay --45 minutes post dose macimorelin	GH 45M p Macimorelin Ser IA-mCnc	null	ACTIVE	2.69	2.69
95850-4	Somatotropin^30M post dose macimorelin	MCnc	Pt	Ser	Qn	IA	CHEM	1	Somatotropin [Mass/volume] in Serum by Immunoassay --30 minutes post dose macimorelin	GH 30M p Macimorelin Ser IA-mCnc	null	ACTIVE	2.69	2.69
9585-1	Babesia sp Ab.IgM	Titr	Pt	Ser	Qn	IF	MICRO	1	Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence	Babesia IgM Titr Ser IF	null	ACTIVE	1.0i	2.73
95851-2	Somatotropin post macimorelin stimulation panel	-	Pt	Ser	-	IA	PANEL.CHEM	1	Somatotropin post macimorelin stimulation panel - Serum by Immunoassay	GH p Macimorelin Stil Pnl Ser IA	null	ACTIVE	2.69	2.69
95852-0	LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Signs and Symptoms of Delirium (from CAM) during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95853-8	LCDS v4.00 - Acute onset and fluctuating course	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Acute onset and fluctuating course during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95854-6	LCDS v4.00 - Cognitive patterns	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Cognitive patterns during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95855-3	Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69
95856-1	LCDS v4.00 - Altered level of consciousness	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Altered level of consciousness during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95857-9	Level of consciousness - Alert (normal)	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Level of consciousness - Alert (normal) during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69
95858-7	Level of consciousness - Vigilant or lethargic or stupor or coma	Find	RptPeriod	^Patient	Ord	CAM.CMS	SURVEY.CMS	4	Level of consciousness - Vigilant or lethargic or stupor or coma during assessment period [CAM.CMS]	null	Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.	ACTIVE	2.69	2.69
95859-5	LCDS v4.00 - Self-care - admission performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Self-care - admission performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95860-3	LCDS v4.00 - Self-care - discharge goal	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Self-care - discharge goal [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95861-1	LCDS v4.00 - Self-care - discharge performance	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Self-care - discharge performance during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95862-9	LCDS v4.00 - Mobility - discharge goal	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Mobility - discharge goal [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95863-7	LCDS v4.00 - Bladder and bowel - planned discharge	-	RptPeriod	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Bladder and bowel - planned discharge during assessment period [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95864-5	LCDS v4.00 - Active diagnoses	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Active diagnoses [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95865-2	LCDS v4.00 - Swallowing &or nutritional status	-	Pt	^Patient	-	CMS Assessment	PANEL.SURVEY.CMS	4	LCDS v4.00 - Swallowing/nutritional status [CMS Assessment]	null	null	ACTIVE	2.69	2.69
95866-0	BRIEF health literacy screening tool	-	Pt	^Patient	-	BRIEF	PANEL.SURVEY.BRIEF	4	BRIEF health literacy screening tool [BRIEF]	null	null	ACTIVE	2.69	2.69
95867-8	Help reading hospital materials	Find	Pt	^Patient	Ord	null	CLIN	2	Help reading hospital materials	Help read hosp materials	null	ACTIVE	2.69	2.69
95868-6	Difficulty understanding written information about medical condition	Find	Pt	^Patient	Ord	null	CLIN	2	Difficulty understanding written information about medical condition	Diff understand med cond	null	ACTIVE	2.69	2.69
9586-9	Borrelia burgdorferi Ab	Imp	Pt	Ser	Nom	null	MICRO	1	Borrelia burgdorferi Ab [Interpretation] in Serum	B burgdor Ab Ser-Imp	null	ACTIVE	1.0i	2.73
95869-4	Problem understanding medical condition	Find	Pt	^Patient	Ord	null	CLIN	2	Problem understanding medical condition	Prob understand med cond	null	ACTIVE	2.69	2.69
95870-2	Confidence filling out medical forms	Find	Pt	^Patient	Ord	null	CLIN	2	Confidence filling out medical forms	Conf fill med form	null	ACTIVE	2.69	2.69
95871-0	Total score	Score	Pt	^Patient	Qn	BRIEF	SURVEY.BRIEF	4	Total score [BRIEF]	null	null	ACTIVE	2.69	2.72
95872-8	Brief cognitive assessment tool short form	-	Pt	^Patient	-	BCAT	PANEL.SURVEY.GNHLTH	4	Brief cognitive assessment tool short form [BCAT]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
95873-6	BCAT short form total score	Score	Pt	^Patient	Qn	BCAT	SURVEY.GNHLTH	4	BCAT short form total score [BCAT]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
95874-4	BCAT short form memory score	Score	Pt	^Patient	Qn	BCAT	SURVEY.GNHLTH	4	BCAT short form memory score [BCAT]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
95875-1	Brief anxiety and depression scale	-	Pt	^Patient	-	BADS	PANEL.SURVEY.MTLHLTH	4	Brief anxiety and depression scale [BADS]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
95876-9	Total score	Score	Pt	^Patient	Qn	BADS	SURVEY.MTLHLTH	4	Total score [BADS]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
9587-7	Borrelia burgdorferi 41kD Ab.IgM	PrThr	Pt	Ser	Ord	IB	MICRO	1	Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot	B burgdor41kD IgM Ser Ql IB	null	ACTIVE	1.0i	2.73
95877-7	Depression score	Score	Pt	^Patient	Qn	BADS	SURVEY.MTLHLTH	4	Depression score [BADS]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
95878-5	Anxiety score	Score	Pt	^Patient	Qn	BADS	SURVEY.MTLHLTH	4	Anxiety score [BADS]	null	© 2012 Dr. William Mansbach. Used with permission.	ACTIVE	2.69	2.69
95879-3	Healthcare personnel with known health status	Num	Pt	^Event	Qn	null	PUBLICHEALTH	2	Healthcare personnel with known health status [#]	HCP with known health status	null	ACTIVE	2.69	2.69
95880-1	Hospitalizations/100,000 population	NFr	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Event-associated hospitalization rate per 100,000 population in a reporting period	Hospitalization rate per 100,000 RptPeriod	null	ACTIVE	2.69	2.69
95881-9	Laboratory test results reported	Num	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Event-associated test results reported [#] during reporting period	Lab test results reported in RptPeriod	null	ACTIVE	2.69	2.69
95882-7	Positive laboratory test results reported	Num	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Positive event-associated test results reported [#] during reporting period	Pos lab test results in RptPeriod	null	ACTIVE	2.69	2.69
95883-5	Positive laboratory test results reported/Laboratory test results reported	NFr	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Percent positive event-associated test results reported [#] during reporting period	% pos lab test results in RptPeriod	null	ACTIVE	2.69	2.69
95884-3	Data collected	Date	Pt	Report	Qn	null	PUBLICHEALTH	2	Date data collected for Report	Date data collected for Report	null	ACTIVE	2.69	2.69
9588-5	Borrelia burgdorferi 18kD Ab.IgG	PrThr	Pt	Ser	Ord	IB	MICRO	1	Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot	B burgdor18kD IgG Ser Ql IB	null	ACTIVE	1.0i	2.73
95885-0	Inpatient beds	Num	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Inpatient beds [#]	Inpt beds	null	ACTIVE	2.69	2.69
95886-8	Inpatient beds occupied	Num	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Inpatient beds occupied [#]	Inpt beds occup	null	ACTIVE	2.69	2.69
95887-6	Inpatient beds occupied/Inpatient beds	NFr	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Inpatient beds occupied/Inpatient beds	Inpt beds occup/Inpt beds NFr	null	ACTIVE	2.69	2.69
95888-4	Inpatient beds occupied by patients with disease of interest	Num	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Inpatient beds occupied by patients with disease of interest [#]	Beds occup w illness	null	ACTIVE	2.69	2.69
95889-2	Inpatient beds occupied by patients with disease of interest/Inpatient beds occupied	NFr	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Inpatient beds occupied by patients with disease of interest/Inpatient beds occupied	Beds occup w illness/Inpt beds occup NFr	null	ACTIVE	2.69	2.69
958-9	C super little w Ag	PrThr	Pt	RBC^BPU	Ord	null	BLDBK	1	C sup(w) Ag [Presence] on Red Blood Cells from Blood product unit	C sup(w) Ag RBC BPU Ql	null	ACTIVE	1.0	2.7
95890-0	Intensive care unit beds occupied	Num	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Intensive care unit beds occupied [#]	ICU beds occupied	null	ACTIVE	2.69	2.69
95891-8	Intensive care unit beds occupied/Intensive care unit beds	NFr	Pt	{Setting}	Qn	null	PUBLICHEALTH	2	Intensive care unit beds occupied/ICU beds	ICU beds occupied/ICU beds NFr	null	ACTIVE	2.69	2.69
95892-6	Healthcare personnel status	-	Pt	^Event	-	CDC.EOC	PANEL.SURVEY.CDC	4	Healthcare personnel status [CDC Emergency Operations Centers]	null	null	ACTIVE	2.69	2.69
9589-3	Borrelia burgdorferi 23kD Ab.IgG	PrThr	Pt	Ser	Ord	IB	MICRO	1	Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot	B burgdor23kD IgG Ser Ql IB	null	ACTIVE	1.0i	2.73
95893-4	Hospital or facility beds utilization panel	-	Pt	^Event	-	CDC.EOC	PANEL.SURVEY.CDC	4	Hospital or facility beds utilization panel [CDC Emergency Operations Centers]	null	null	ACTIVE	2.69	2.69
95894-2	Deaths/100,000 population	NFr	Pt	^Event	Qn	null	PUBLICHEALTH	2	Total event-associated death rate per 100,000 population	Death rate per 100,000 pop	null	ACTIVE	2.69	2.69
95895-9	Start date	Date	Pt	^Event	Qn	null	PUBLICHEALTH	2	Event start date	Event start date	null	ACTIVE	2.69	2.69
95896-7	Increase or decrease in cases compared to previous reporting period	NumDiff	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Increase or decrease in event-associated cases compared to previous reporting period [#]	Event cases # since prev RptPeriod	null	ACTIVE	2.69	2.69
95897-5	Percent increase or decrease in cases compared to previous reporting period	PctDiff	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Percent increase or decrease in event-associated cases compared to previous reporting period	% diff in cases since prev RptPeriod	null	ACTIVE	2.69	2.69
95898-3	All-cause deaths since start of event	Num	Pt	^Population	Qn	null	PUBLICHEALTH	2	All-cause deaths since start of event	All-cause deaths since start of event	null	ACTIVE	2.69	2.69
95899-1	Deaths	Num	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Event-associated deaths [#] during reporting period	Event deaths # in RptPeriod	null	ACTIVE	2.69	2.69
95900-7	Percent increase or decrease in deaths compared to previous reporting period	PctDiff	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Percent increase or decrease in event-associated deaths compared to previous reporting period	% diff in deaths since prev RptPeriod	null	ACTIVE	2.69	2.69
9590-1	Borrelia burgdorferi 28kD Ab.IgG	PrThr	Pt	Ser	Ord	IB	MICRO	1	Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot	B burgdor28kD IgG Ser Ql IB	null	ACTIVE	1.0i	2.73
95901-5	Hospitalizations	Num	RptPeriod	^Event	Qn	null	PUBLICHEALTH	2	Event-associated hospitalizations [#] during reporting period	Hospitalizations # in RptPeriod	null	ACTIVE	2.69	2.69
95902-3	Hospitalizations	Num	Pt	^Event	Qn	null	PUBLICHEALTH	2	Total event-associated hospitalizations [#]	Total Event hospitalizations	null	ACTIVE	2.69	2.69
95903-1	Cases among healthcare personnel	Num	Pt	^Event	Qn	null	PUBLICHEALTH	2	Total event-associated cases among healthcare personnel [#]	Total Event cases among HCP	null	ACTIVE	2.69	2.69

95814-0

Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Was the patient's thinking disorganized or incoherent, such as rambling or irrelevant conversation, unclear or illogical flow of ideas, or unpredictable switching from subject to subject during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69

95815-7

Altered level of consciousness

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Altered level of consciousness during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69

95816-5

Signs and Symptoms of Delirium (from CAM)

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

Signs and symptoms of delirium (from CAM) during assessment period [CMS Assessment]

null

ACTIVE

2.69

2.72

95817-3

Oxygen/Gas.total

VFr

24H^max

Inhl gas

Qn

null

CLIN

2

Oxygen/Gas total 24 hour maximum Inhaled gas

FIO2 24h Max

null

ACTIVE

2.69

95818-1

Intravascular mean^during anesthesia

Pres

Pt

Pulmonary artery

Qn

null

BP.MOLEC

2

Pulmonary artery Mean blood pressure--during anesthesia

PA BP mean--during anesthesia

null

ACTIVE

2.69

95819-9

Intravascular diastolic^during anesthesia

Pres

Pt

Pulmonary artery

Qn

null

BP.MOLEC

2

Pulmonary artery Diastolic blood pressure--during anesthesia

PA BP dias--during anesthesia

null

ACTIVE

2.69

95820-7

Intravascular systolic^during anesthesia

Pres

Pt

Pulmonary artery

Qn

null

BP.MOLEC

2

Pulmonary artery Systolic blood pressure--during anesthesia

PA BP sys--during anesthesia

null

ACTIVE

2.69

95821-5

Intravascular mean^during anesthesia

Pres

Pt

Arterial system

Qn

Noninvasive

BP.MOLEC

2

Mean blood pressure by Noninvasive--during anesthesia

BP mean by Noninv--during anesthesia

null

ACTIVE

2.69

95822-3

Intravascular mean^during anesthesia

Pres

Pt

Arterial system

Qn

null

BP.MOLEC

2

Mean blood pressure--during anesthesia

BP mean--during anesthesia

null

ACTIVE

2.69

95823-1

SARS-related coronavirus E gene

PrThr

Pt

Saliva

Ord

Probe.amp.tar

MICRO

1

SARS-related coronavirus E gene [Presence] in Saliva (oral fluid) by NAA with probe detection

SARS-rel CoV E gene Sal Ql NAA+probe

null

ACTIVE

2.69

95824-9

SARS coronavirus 2 ORF1ab region

PrThr

Pt

Saliva

Ord

Probe.amp.tar

MICRO

1

SARS-CoV-2 (COVID-19) ORF1ab region [Presence] in Saliva (oral fluid) by NAA with probe detection

SARS-CoV-2 ORF1ab Sal Ql NAA+probe

null

ACTIVE

2.69

95825-6

SARS coronavirus 2 Ab

PrThr

Pt

Bld.dot

Ord

IA

MICRO

1

SARS-CoV-2 (COVID-19) Ab [Presence] in DBS by Immunoassay

SARS-CoV-2 Ab DBS Ql IA

null

ACTIVE

2.69

95826-4

SARS coronavirus 2 RNA panel

-

Pt

Saliva

-

Probe.amp.tar

PANEL.MICRO

1

SARS-CoV-2 (COVID-19) RNA panel - Saliva (oral fluid) by NAA with probe detection

SARS-CoV-2 RNA Pnl Sal NAA+probe

null

ACTIVE

2.69

2.7

95827-2

Viable CD3 cells/100 cells.CD3

NFr

Pt

^BPU

Qn

null

BLDBK

1

Viable CD3 cells/100 CD3 cells in Blood product unit

Viable CD3 cells/100 CD3 NFr BPU

null

ACTIVE

2.69

9582-8

Afipia felis Ab.IgG

Titr

Pt

Ser

Qn

IF

MICRO

1

Afipia felis IgG Ab [Titer] in Serum by Immunofluorescence

A felis IgG Titr Ser IF

null

ACTIVE

1.0i

2.7

95828-0

T cell product characterization panel

-

Pt

^BPU

-

Flow cytometry

PANEL.BLDBK

1

T cell product characterization panel - Blood product unit by Flow cytometry (FC)

T cell product panel BPU FC

null

ACTIVE

2.69

95829-8

Viable CD45 cells/100 cells.CD45

NFr

Pt

^BPU

Qn

null

BLDBK

1

Viable CD45 cells/100 CD45 cells in Blood product unit

Viable CD45 cells/100 CD45 NFr BPU

null

ACTIVE

2.69

95830-6

Hematopoietic progenitor cell product characterization panel

-

Pt

^BPU

-

Flow cytometry

PANEL.BLDBK

1

Hematopoietic progenitor cell product characterization panel - Blood product unit by Flow cytometry (FC)

HPC product panel BPU FC

null

ACTIVE

2.69

95831-4

Lymphocyte dose in hematopoietic progenitor cell transfusion

NCnt

Pt

^Patient

Qn

null

BLDBK

1

Lymphocyte dose in hematopoietic progenitor cell transfusion [#/mass]

Lymphocyte dose in HPC trsplt Patient

null

ACTIVE

2.69

95832-2

CD3 dose in hematopoietic progenitor cell transfusion

NCnt

Pt

^Patient

Qn

null

BLDBK

1

CD3 dose in hematopoietic progenitor cell transfusion [#/mass]

CD3 dose in HPC transplant Patient

null

ACTIVE

2.69

95833-0

Nucleated cells

Num

Pt

^BPU

Qn

null

BLDBK

1

Nucleated cells [#] in Blood product unit

Nuc cell BPU

null

ACTIVE

2.69

95834-8

Mononuclear cells

Num

Pt

^BPU

Qn

null

BLDBK

1

Mononuclear cells [#] in Blood product unit

Mononuc Cells BPU

null

ACTIVE

2.69

95835-5

Cells.CD34

Num

Pt

^BPU

Qn

null

BLDBK

1

CD34 cells [#] in Blood product unit

CD34 Cells BPU

null

ACTIVE

2.69

9583-6

Afipia felis Ab.IgM

Titr

Pt

Ser

Qn

IF

MICRO

1

Afipia felis IgM Ab [Titer] in Serum by Immunofluorescence

A felis IgM Titr Ser IF

null

ACTIVE

1.0i

2.7

95836-3

Cells.CD3

Num

Pt

^BPU

Qn

null

BLDBK

1

CD3 cells [#] in Blood product unit

CD3 Cells BPU

null

ACTIVE

2.69

95837-1

Mononuclear cell dose in hematopoietic progenitor cell transfusion

NCnt

Pt

^Patient

Qn

null

BLDBK

1

Mononuclear cell dose in hematopoietic progenitor cell transfusion [#/mass]

Mono Cell dose in HPC transplant Patient

null

ACTIVE

2.69

95838-9

Nucleated cells.recovered/Nucleated cells.total

NFr

Pt

^Patient

Qn

null

BLDBK

1

Nucleated cells.recovered/Nucleated cells.total

TNC Recovered/TNC NFr Patient

null

ACTIVE

2.69

95839-7

Mononuclear cells.recovered/Mononuclear cells.total

NFr

Pt

^Patient

Qn

null

BLDBK

1

Mononuclear cells.recovered/Mononuclear cells.total

Monos Recovered/Monos Total NFr Patient

null

ACTIVE

2.69

95840-5

Microscopic exam

Imp

Pt

Sputum

Nar

Microscopy

HEM/BC

1

Microscopic exam [Interpretation] in Sputum by Microscopy Narrative

Microscopic Spt Micro-Imp

null

ACTIVE

2.69

95841-3

Monocytes+Macrophages/100 leukocytes

NFr

Pt

Sputum

Qn

Manual count

HEM/BC

1

Monocytes+Macrophages/100 leukocytes in Sputum by Manual count

Monos+Macros/leuk NFr Spt Manual

null

ACTIVE

2.69

95842-1

Lymphocytes/100 leukocytes

NFr

Pt

Sputum

Qn

Manual count

HEM/BC

1

Lymphocytes/100 leukocytes in Sputum by Manual count

Lymphocytes/leuk NFr Spt Manual

null

ACTIVE

2.69

95843-9

Neutrophils/100 leukocytes

NFr

Pt

Sputum

Qn

Manual count

HEM/BC

1

Neutrophils/100 leukocytes in Sputum by Manual count

Neutrophils/leuk NFr Spt Manual

null

ACTIVE

2.69

9584-4

Babesia sp Ab.IgG

Titr

Pt

Ser

Qn

IF

MICRO

1

Babesia sp IgG Ab [Titer] in Serum by Immunofluorescence

Babesia IgG Titr Ser IF

null

ACTIVE

1.0i

2.73

95844-7

Epithelial cells.squamous

NCnc

Pt

Sputum

Qn

Manual count

HEM/BC

1

Epithelial cells.squamous [#/volume] in Sputum by Manual count

Squamous # Spt Manual

null

ACTIVE

2.69

95845-4

Nucleated cells

NCnc

Pt

Sputum

Qn

Manual count

HEM/BC

1

Nucleated cells [#/volume] in Sputum by Manual count

Nuc cell # Spt Manual

null

ACTIVE

2.69

95846-2

Cell count & Differential panel

-

Pt

Sputum

Qn

Manual count

PANEL.HEM/BC

1

Cell count and Differential panel - Sputum by Manual count

Cell Cnt + Diff Pnl Spt Manual

null

ACTIVE

2.69

95847-0

Somatotropin^90M post dose macimorelin

MCnc

Pt

Ser

Qn

IA

CHEM

1

Somatotropin [Mass/volume] in Serum by Immunoassay --90 minutes post dose macimorelin

GH 90M p Macimorelin Ser IA-mCnc

null

ACTIVE

2.69

95848-8

Somatotropin^60M post dose macimorelin

MCnc

Pt

Ser

Qn

IA

CHEM

1

Somatotropin [Mass/volume] in Serum by Immunoassay --60 minutes post dose macimorelin

GH 60M p Macimorelin Ser IA-mCnc

null

ACTIVE

2.69

95849-6

Somatotropin^45M post dose macimorelin

MCnc

Pt

Ser

Qn

IA

CHEM

1

Somatotropin [Mass/volume] in Serum by Immunoassay --45 minutes post dose macimorelin

GH 45M p Macimorelin Ser IA-mCnc

null

ACTIVE

2.69

95850-4

Somatotropin^30M post dose macimorelin

MCnc

Pt

Ser

Qn

IA

CHEM

1

Somatotropin [Mass/volume] in Serum by Immunoassay --30 minutes post dose macimorelin

GH 30M p Macimorelin Ser IA-mCnc

null

ACTIVE

2.69

9585-1

Babesia sp Ab.IgM

Titr

Pt

Ser

Qn

IF

MICRO

1

Babesia sp IgM Ab [Titer] in Serum by Immunofluorescence

Babesia IgM Titr Ser IF

null

ACTIVE

1.0i

2.73

95851-2

Somatotropin post macimorelin stimulation panel

-

Pt

Ser

-

IA

PANEL.CHEM

1

Somatotropin post macimorelin stimulation panel - Serum by Immunoassay

GH p Macimorelin Stil Pnl Ser IA

null

ACTIVE

2.69

95852-0

LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Signs and Symptoms of Delirium (from CAM) during assessment period [CMS Assessment]

null

ACTIVE

2.69

95853-8

LCDS v4.00 - Acute onset and fluctuating course

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Acute onset and fluctuating course during assessment period [CMS Assessment]

null

ACTIVE

2.69

95854-6

LCDS v4.00 - Cognitive patterns

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Cognitive patterns during assessment period [CMS Assessment]

null

ACTIVE

2.69

95855-3

Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Did the (abnormal) behavior fluctuate during the day, that is, tend to come and go or increase and decrease in severity during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69

95856-1

LCDS v4.00 - Altered level of consciousness

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Altered level of consciousness during assessment period [CMS Assessment]

null

ACTIVE

2.69

95857-9

Level of consciousness - Alert (normal)

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Level of consciousness - Alert (normal) during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69

95858-7

Level of consciousness - Vigilant or lethargic or stupor or coma

Find

RptPeriod

^Patient

Ord

CAM.CMS

SURVEY.CMS

4

Level of consciousness - Vigilant or lethargic or stupor or coma during assessment period [CAM.CMS]

null

Copyright © 2003 Sharon K. Inouye, M.D., MPH. Adapted from: Inouye SK, vanDyck CH, Alessi CA, Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: The Confusion Assessment Method. A new method for detection of delirium. Ann Intern Med. 1990; 113: 941-948. Confusion Assessment Method: Training Manual and Coding Guide. Used with permission.

ACTIVE

2.69

95859-5

LCDS v4.00 - Self-care - admission performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Self-care - admission performance during assessment period [CMS Assessment]

null

ACTIVE

2.69

95860-3

LCDS v4.00 - Self-care - discharge goal

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Self-care - discharge goal [CMS Assessment]

null

ACTIVE

2.69

95861-1

LCDS v4.00 - Self-care - discharge performance

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Self-care - discharge performance during assessment period [CMS Assessment]

null

ACTIVE

2.69

95862-9

LCDS v4.00 - Mobility - discharge goal

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Mobility - discharge goal [CMS Assessment]

null

ACTIVE

2.69

95863-7

LCDS v4.00 - Bladder and bowel - planned discharge

-

RptPeriod

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Bladder and bowel - planned discharge during assessment period [CMS Assessment]

null

ACTIVE

2.69

95864-5

LCDS v4.00 - Active diagnoses

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Active diagnoses [CMS Assessment]

null

ACTIVE

2.69

95865-2

LCDS v4.00 - Swallowing &or nutritional status

-

Pt

^Patient

-

CMS Assessment

PANEL.SURVEY.CMS

4

LCDS v4.00 - Swallowing/nutritional status [CMS Assessment]

null

ACTIVE

2.69

95866-0

BRIEF health literacy screening tool

-

Pt

^Patient

-

BRIEF

PANEL.SURVEY.BRIEF

4

BRIEF health literacy screening tool [BRIEF]

null

ACTIVE

2.69

95867-8

Help reading hospital materials

Find

Pt

^Patient

Ord

null

CLIN

2

Help reading hospital materials

Help read hosp materials

null

ACTIVE

2.69

95868-6

Difficulty understanding written information about medical condition

Find

Pt

^Patient

Ord

null

CLIN

2

Difficulty understanding written information about medical condition

Diff understand med cond

null

ACTIVE

2.69

9586-9

Borrelia burgdorferi Ab

Imp

Pt

Ser

Nom

null

MICRO

1

Borrelia burgdorferi Ab [Interpretation] in Serum

B burgdor Ab Ser-Imp

null

ACTIVE

1.0i

2.73

95869-4

Problem understanding medical condition

Find

Pt

^Patient

Ord

null

CLIN

2

Problem understanding medical condition

Prob understand med cond

null

ACTIVE

2.69

95870-2

Confidence filling out medical forms

Find

Pt

^Patient

Ord

null

CLIN

2

Confidence filling out medical forms

Conf fill med form

null

ACTIVE

2.69

95871-0

Total score

Score

Pt

^Patient

Qn

BRIEF

SURVEY.BRIEF

4

Total score [BRIEF]

null

ACTIVE

2.69

2.72

95872-8

Brief cognitive assessment tool short form

-

Pt

^Patient

-

BCAT

PANEL.SURVEY.GNHLTH

4

Brief cognitive assessment tool short form [BCAT]

null

ACTIVE

2.69

95873-6

BCAT short form total score

Score

Pt

^Patient

Qn

BCAT

SURVEY.GNHLTH

4

BCAT short form total score [BCAT]

null

ACTIVE

2.69

95874-4

BCAT short form memory score

Score

Pt

^Patient

Qn

BCAT

SURVEY.GNHLTH

4

BCAT short form memory score [BCAT]

null

ACTIVE

2.69

95875-1

Brief anxiety and depression scale

-

Pt

^Patient

-

BADS

PANEL.SURVEY.MTLHLTH

4

Brief anxiety and depression scale [BADS]

null

ACTIVE

2.69

95876-9

Total score

Score

Pt

^Patient

Qn

BADS

SURVEY.MTLHLTH

4

Total score [BADS]

null

ACTIVE

2.69

9587-7

Borrelia burgdorferi 41kD Ab.IgM

PrThr

Pt

Ser

Ord

IB

MICRO

1

Borrelia burgdorferi 41kD IgM Ab [Presence] in Serum by Immunoblot

B burgdor41kD IgM Ser Ql IB

null

ACTIVE

1.0i

2.73

95877-7

Depression score

Score

Pt

^Patient

Qn

BADS

SURVEY.MTLHLTH

4

Depression score [BADS]

null

ACTIVE

2.69

95878-5

Anxiety score

Score

Pt

^Patient

Qn

BADS

SURVEY.MTLHLTH

4

Anxiety score [BADS]

null

ACTIVE

2.69

95879-3

Healthcare personnel with known health status

Num

Pt

^Event

Qn

null

PUBLICHEALTH

2

Healthcare personnel with known health status [#]

HCP with known health status

null

ACTIVE

2.69

95880-1

Hospitalizations/100,000 population

NFr

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Event-associated hospitalization rate per 100,000 population in a reporting period

Hospitalization rate per 100,000 RptPeriod

null

ACTIVE

2.69

95881-9

Laboratory test results reported

Num

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Event-associated test results reported [#] during reporting period

Lab test results reported in RptPeriod

null

ACTIVE

2.69

95882-7

Positive laboratory test results reported

Num

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Positive event-associated test results reported [#] during reporting period

Pos lab test results in RptPeriod

null

ACTIVE

2.69

95883-5

Positive laboratory test results reported/Laboratory test results reported

NFr

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Percent positive event-associated test results reported [#] during reporting period

% pos lab test results in RptPeriod

null

ACTIVE

2.69

95884-3

Data collected

Date

Pt

Report

Qn

null

PUBLICHEALTH

2

Date data collected for Report

null

ACTIVE

2.69

9588-5

Borrelia burgdorferi 18kD Ab.IgG

PrThr

Pt

Ser

Ord

IB

MICRO

1

Borrelia burgdorferi 18kD IgG Ab [Presence] in Serum by Immunoblot

B burgdor18kD IgG Ser Ql IB

null

ACTIVE

1.0i

2.73

95885-0

Inpatient beds

Num

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Inpatient beds [#]

Inpt beds

null

ACTIVE

2.69

95886-8

Inpatient beds occupied

Num

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Inpatient beds occupied [#]

Inpt beds occup

null

ACTIVE

2.69

95887-6

Inpatient beds occupied/Inpatient beds

NFr

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Inpatient beds occupied/Inpatient beds

Inpt beds occup/Inpt beds NFr

null

ACTIVE

2.69

95888-4

Inpatient beds occupied by patients with disease of interest

Num

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Inpatient beds occupied by patients with disease of interest [#]

Beds occup w illness

null

ACTIVE

2.69

95889-2

Inpatient beds occupied by patients with disease of interest/Inpatient beds occupied

NFr

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Inpatient beds occupied by patients with disease of interest/Inpatient beds occupied

Beds occup w illness/Inpt beds occup NFr

null

ACTIVE

2.69

958-9

C super little w Ag

PrThr

Pt

RBC^BPU

Ord

null

BLDBK

1

C sup(w) Ag [Presence] on Red Blood Cells from Blood product unit

C sup(w) Ag RBC BPU Ql

null

ACTIVE

1.0

2.7

95890-0

Intensive care unit beds occupied

Num

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Intensive care unit beds occupied [#]

ICU beds occupied

null

ACTIVE

2.69

95891-8

Intensive care unit beds occupied/Intensive care unit beds

NFr

Pt

{Setting}

Qn

null

PUBLICHEALTH

2

Intensive care unit beds occupied/ICU beds

ICU beds occupied/ICU beds NFr

null

ACTIVE

2.69

95892-6

Healthcare personnel status

-

Pt

^Event

-

CDC.EOC

PANEL.SURVEY.CDC

4

Healthcare personnel status [CDC Emergency Operations Centers]

null

ACTIVE

2.69

9589-3

Borrelia burgdorferi 23kD Ab.IgG

PrThr

Pt

Ser

Ord

IB

MICRO

1

Borrelia burgdorferi 23kD IgG Ab [Presence] in Serum by Immunoblot

B burgdor23kD IgG Ser Ql IB

null

ACTIVE

1.0i

2.73

95893-4

Hospital or facility beds utilization panel

-

Pt

^Event

-

CDC.EOC

PANEL.SURVEY.CDC

4

Hospital or facility beds utilization panel [CDC Emergency Operations Centers]

null

ACTIVE

2.69

95894-2

Deaths/100,000 population

NFr

Pt

^Event

Qn

null

PUBLICHEALTH

2

Total event-associated death rate per 100,000 population

Death rate per 100,000 pop

null

ACTIVE

2.69

95895-9

Start date

Date

Pt

^Event

Qn

null

PUBLICHEALTH

2

Event start date

null

ACTIVE

2.69

95896-7

Increase or decrease in cases compared to previous reporting period

NumDiff

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Increase or decrease in event-associated cases compared to previous reporting period [#]

Event cases # since prev RptPeriod

null

ACTIVE

2.69

95897-5

Percent increase or decrease in cases compared to previous reporting period

PctDiff

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Percent increase or decrease in event-associated cases compared to previous reporting period

% diff in cases since prev RptPeriod

null

ACTIVE

2.69

95898-3

All-cause deaths since start of event

Num

Pt

^Population

Qn

null

PUBLICHEALTH

2

All-cause deaths since start of event

null

ACTIVE

2.69

95899-1

Deaths

Num

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Event-associated deaths [#] during reporting period

Event deaths # in RptPeriod

null

ACTIVE

2.69

95900-7

Percent increase or decrease in deaths compared to previous reporting period

PctDiff

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Percent increase or decrease in event-associated deaths compared to previous reporting period

% diff in deaths since prev RptPeriod

null

ACTIVE

2.69

9590-1

Borrelia burgdorferi 28kD Ab.IgG

PrThr

Pt

Ser

Ord

IB

MICRO

1

Borrelia burgdorferi 28kD IgG Ab [Presence] in Serum by Immunoblot

B burgdor28kD IgG Ser Ql IB

null

ACTIVE

1.0i

2.73

95901-5

Hospitalizations

Num

RptPeriod

^Event

Qn

null

PUBLICHEALTH

2

Event-associated hospitalizations [#] during reporting period

Hospitalizations # in RptPeriod

null

ACTIVE

2.69

95902-3

Hospitalizations

Num

Pt

^Event

Qn

null

PUBLICHEALTH

2

Total event-associated hospitalizations [#]

Total Event hospitalizations

null

ACTIVE

2.69

95903-1

Cases among healthcare personnel

Num

Pt

^Event

Qn

null

PUBLICHEALTH

2

Total event-associated cases among healthcare personnel [#]

Total Event cases among HCP

null

ACTIVE

2.69